AVROBIO, Inc(NASDAQ:AVRO) 
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functio...
Website: http://www.avrobio.com
Founded: 2015
Full Time Employees: 123
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-12-21
P
O 1.33
H 1.36
L 1.33
C 1.34
V 62,069
10EMA 1.34
20EMA 1.34
60EMA 1.34
120EMA 1.34
250EMA 1.34